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IBD syndromes such as Crohn’s disease and ulcera-
tive colitis result from the inflammation of specific
intestinal segments. Although many studies have
reported on the regenerative response of intestinal
progenitor and stem cells to tissue injury, very little
is known about the response of differentiated line-
ages to inflammatory cues. Here, we show that acute
inflammation of the mouse small intestine is followed
by a dramatic loss of Lgr5+ stem cells. Instead, Pan-
eth cells re-enter the cell cycle, lose their secretory
expression signature, and acquire stem-like proper-
ties, thus contributing to the tissue regenerative
response to inflammation. Stem cell factor secretion
upon inflammation triggers signaling through the
c-Kit receptor and a cascade of downstream events
culminating in GSK3b inhibition andWnt activation in
Paneth cells. Hence, the plasticity of the intestinal
epithelium in response to inflammation goes well
beyond stem and progenitor cells and extends to
the fully differentiated and post-mitotic Paneth cells.
INTRODUCTION
Adult stem cells have long been postulated to be intrinsically of a
slow-cycling nature, mainly based on the necessity to preserve
the integrity of their genome by preventing mutations occurring
during DNA replication (Fuchs, 2009). In the hematopoietic field
in particular, there is general consensus regarding the inverse
correlation between cycling frequency and long-term stem cell
activity (Orford and Scadden, 2008). However, tissues charac-
terized by a high cellular turnover (e.g., intestine, skin) seem
to represent notable exceptions to these rules of thumb because
highly proliferative stem cells—e.g., the Lgr5+ crypt base
columnar (CBC) cells in the intestinal crypt of Lieberk€uhn (Barker
et al., 2007)—have a remarkable long-term self-renewal capac-2312 Cell Reports 24, 2312–2328, August 28, 2018 ª 2018 The Autho
This is an open access article under the CC BY license (http://creativeity. In these cases, a dichotomy of cycling and more quiescent
stem cell lineages is thought to coexist within the niche; although
actively cycling stem cells underlie daily homeostasis, their
more quiescent equivalents are thought to play key roles in the
response to tissue damage, upon which they re-enter the cell
cycle, thus contributing to the regeneration process (Fuchs,
2009).
In the intestinal epithelium, Lgr5+ stem cells are positioned at
the very crypt bottom (position +1), usually flanked on both sides
by secretory Paneth cells (PCs) in the small intestine and by anal-
ogous Paneth-like cells in the colon (Rothenberg et al., 2012;
Sasaki et al., 2016; Sato et al., 2011; Schewe et al., 2016). Of
note, apart from their canonical antimicrobial function, exerted
through the secretion of bactericidal compounds into the lumen
(Clevers and Bevins, 2013), PCs have also been shown to play
an essential niche role in supporting Lgr5+ CBC cells both
through cell-cell contacts and by secreting specific factors
such as epidermal growth factor (EGF), Wnt3a, and Dll4 (Sato
et al., 2011).
As for the less proliferative intestinal stem cell types, to date,
several candidates have been identified and partially character-
ized (Roth and Fodde, 2011). Among others, cells located at po-
sition +4 from the base of the crypt and earmarked by Bmi1
expression have been shown to self-renew and give rise to all
of the differentiated cell lineages of the small intestine epithelium
(Sangiorgi and Capecchi, 2008). Notably, the +4 position of
these Bmi1+ stem cells is reminiscent of the bromodeoxyuridine
(BrdU)-retaining cells originally identified by Potten (1998). How-
ever, the marker genes identified to date as proxies of these
quiescent cell types are often not unique to a specific stem cell
lineage but, rather, co-expressed at lower levels in other cells
(Clevers, 2016; Gr€un et al., 2016; Li et al., 2014; Mun˜oz et al.,
2012).
Previously, we employed an in vivo label-retainingmethod as a
marker-free approach for the isolation of infrequently dividing
cells and identified PCs and their precursors as the least cycling
and longest-lasting intestinal cell lineage. Notably, we showed
that, upon tissue injury, these secretory cells and their
immature precursors are capable of losing expression of somers.
commons.org/licenses/by/4.0/).
(legend on next page)
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Paneth-specific genes (Roth et al., 2012). More recently, Buc-
zacki et al. (2013) showed that label-retaining cells located at
around position +3/+4 represent precursors committed to the
Paneth and entero-endocrine lineages but are also potentially
capable of giving rise to all intestinal cell types. These findings
suggest that committed progenitors, and possibly even fully
differentiated and post-mitotic intestinal lineages, as postulated
in the present study, may serve as an alternative source of stem
cells contributing to the regenerative response to tissue damage.
Accordingly, irradiation-induced injury is usually accompanied
by loss of CBC cells and de-differentiation of secretory progen-
itor cells earmarked by Dll1 expression (usually located at posi-
tion +5 or higher) into stem-like cells (van Es et al., 2012). In addi-
tion to secretory lineages, enterocyte progenitors expressing
the intestinal alkaline phosphate (Alpi) gene have also been
shown to regain stem cell potential upon Lgr5+ CBCs ablation
(Tetteh et al., 2016).
The role played by precursors of secretory lineages, and in
particular by PCs, in the regenerative response to intestinal tis-
sue damage is of interest especially in the context of inflamma-
tory bowel disease (IBD), a cumulative name for syndromes
such as Crohn’s disease (CD) and ulcerative colitis (UC) featuring
chronic inflammation of either both the small and large intestine
(CD) or only the colon (UC) (Clevers and Bevins, 2013; Schewe
and Fodde, 2018). In particular, CD has been shown to be a
disorder of the PC, and, vice versa, PCs are regarded as the
site of origin of intestinal inflammation in CD because defects
in its unfolded protein response function are likely to trigger the
inflammatory reaction (Adolph et al., 2013).
In this study, we elucidated the role played by PCs, a terminally
differentiated and post-mitotic secretory lineage, in the regener-
ative response to inflammation and its capacity to de-differen-
tiate and acquire stem cell characteristics to contribute to intes-
tinal regeneration. Of note, the expression of stem cell factor
(SCF) (i.e., the ligand of the c-Kit receptor specifically expressed
in PCs) is enhanced in IBD patients, and the DSS (dextran so-
dium sulfate) model. Indeed, the mechanisms underlying PC
de-differentiation and stemness acquisition rely on activation
of phosphatidylinositol 3-kinase (PI3K)/Akt andWnt downstream
of the SCF/c-Kit signaling axis.Figure 1. SCF Expression Is Increased upon Intestinal Inflammation an
(A) Confocal microscopy analysis of Lgr5EGFP-IRES-creERT2 mice using antibodies
(arrows) but not on GFP-labeled Lgr5+ cells (asterisks) (scale bar, 25 mm).
(B) Comparison by IHC analysis of SCF expression in healthy (left) and CD-derive
close to the intestinal crypts. The images are representative of 2 healthy and 4 C
(C) SCF in situ hybridization (ISH) analysis of small intestinal tissues derived from c
SCF RNA levels can be observed in the intestinal epithelium and submucosa of in
200 mm (top) and 50 mm (bottom); grid lines indicate intestinal crypts. Red (stro
expression in proximity to PCs.
(D) Weight loss graphs relative to mice treated with 3% DSS alone, ISCK03 alone
DSS and DSS + ISCK03-treated mice; n = 3 for ISCK03-treated mice).
(E) DAI score relative to the mice described in (B) (*p < 0.05); mean (SD) values a
(F) Organoid multiplicities fromwhole crypts of control and 3%DSS-treated mice
show representative organoids of each condition on day 5 of culture (scale bars
(G) Organoid multiplicities from whole crypts of control and 3% DSS-treated mic
absence of the soluble c-Kit receptor (500 ng/mL) or masitinib (200 nM) (**p < 0.
(H) Organoid multiplicities from whole crypts grown in control medium with or wi
condition on day 5 of culture (scale bars, 50 mm; **p < 0.01; n = 3; mean [SD] va
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Intestinal Expression of the c-Kit Ligand SCF Is
Enhanced in IBD Patients and in Mouse Models of
Pan-gastroenteritis
It has been reported previously that the expression of SCF is
increased in IBD patients (Andersson et al., 2017; Comar et al.,
2012). This observation is of potential interest because the
SCF gene, also known as KITLG, encodes the ligand of the tyro-
sine-kinase receptor c-KIT, known to regulate the survival, main-
tenance, and self-renewal of stem cells (Lennartsson and Ro¨nn-
strand, 2012). Of note, both secretory PCs in the small intestinal
epithelium (Figure 1A, arrows) and Paneth-like cells (PLCs) in the
colon express the c-KIT receptor (Rothenberg et al., 2012). In
contrast, Lgr5+ CBC cells do not express c-KIT (Figure 1A, aster-
isks; Clevers, 2016; Gr€un et al., 2016; Li et al., 2014; Mun˜oz et al.,
2012). In view of the known niche role played by PCs in support-
ing Lgr5+ stem cells (Sato et al., 2011) their own capacity to
respond to tissue damage by re-entering the cell cycle and
acquiring stem-like cell properties (Buczacki et al., 2013; Roth
et al., 2012; Schewe et al., 2016), we set out to study the func-
tional significance of SCF activation upon inflammatory insults
by first validating the upregulation of SCF expression in IBD pa-
tients (i.e., CD and UC) and in the DSS mouse model of acute in-
testinal inflammation of the entire GI tract (pan-gastroenteritis)
(Elsheikh et al., 2012).
SCF immunohistochemistry (IHC) analysis of a small cohort of
IBD patients (n = 9, of which 5 had UC and 4 had CD, together
with normal tissues from two colorectal cancer patients as
controls) revealed increased expression in the epithelial lining
and the mucosa and submucosa of the inflamed small intestinal
and colon tissues from CD and UC patients, respectively (Fig-
ures 1B and S1A). As expected, PC metaplasia was also
frequently observed in the colon of the analyzed IBD patients
(3 of 5 UC patients; Figure S1B). Next we analyzed SCF expres-
sion in the DSS mouse model. DSS was administered orally (3%
in drinking water) for aweek to cause acute inflammation. On day
7 of DSS treatment, intestinal tissues were harvested and
analyzed for SCF expression by RNA in situ hybridization, which
confirmed increased SCF expression in the small intestinald Positively Affects Organoid Growth
against lysozyme and c-Kit. c-Kit is detected at the membrane of Lyz+ PCs
d small intestinal tissues (right). The arrowheads indicate SCF-expressing cells
D patients; scale bars, 100 mm.
ontrol (top) and DSS-treated (bottom) mice 1 day after DSS removal. Increased
flamed mice. Pictures show representative examples of n = 3 mice; scale bars,
mal) and black (intestinal epithelial) arrows indicate cells with increased SCF
(0.1 mg/mL in the drinking water), and 3% DSS + ISCK03 for 7 days (n = 6 for
re shown. Details of scoring are shown in Figure S1D and STAR Methods.
(7 days). Crypts were isolated and plated 3 days after DSS withdrawal. Pictures
, 50 mm; **p < 0.01; n = 4; mean [SD] values are shown).
e (7 days). Crypts were plated 3 days after DSS withdrawal in the presence or
01, n = 3; mean [SD] values are shown).
thout murine SCF (50 ng/mL). Pictures show representative organoids of each
lues are shown).
A B
C D
E
F
(legend on next page)
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epithelium as well as the mucosa and submucosa of the treated
mice (Figures 1C and S1C). RNA probes against PPIB (peptidyl-
prolyl cis-trans isomerase B), here employed as positive con-
trols, showed no differences between control and DSS-treated
mice (Figure S1C).
To assess whether increased SCF/c-Kit signaling plays a crit-
ical role during intestinal inflammation, we inhibited the pathway
by administrating the specific c-Kit inhibitor ISCK03 in the drink-
ing water together with DSS (Na et al., 2007). ISCK03 alone had
no effect on the overall health of the animals, as shown by their
unchanged body weight (Figure 1D), disease activity index
(DAI; Figures 1E and S1D), and infiltrating CD3+ T lymphocyte
multiplicity (Figures S1E and S1F) compared with control mice.
However, mice treated with ISCK03 in combination with DSS
suffered more severely compared with mice treated with DSS
alone, as shown by increased weight loss and DAI scores (Fig-
ures 1D and 1E and S1D) and number of infiltrating CD3+ T lym-
phocytes (Figure S1E).
Overall, these results confirm that expression of the c-Kit
ligand SCF is enhanced upon intestinal inflammation and that
activation of the SCF/c-Kit signaling axis is critical in the physio-
logical response to the inflammatory insult. In view of the multi-
functional nature of PCs and their expression of the c-Kit recep-
tor, we set out to analyze the functional consequences of the
activation of the SCF/c-Kit signaling axis on the intestinal stem
cell niche.
Inflammation-Driven SCF Expression Enhances
Intestinal Stem Cell Function
To study the effects of inflammation and enhanced SCF expres-
sion on the intestinal stem cell niche, we employed ex vivo ‘‘mini-
gut’’ organoid formation as a readout of stemness (Sato et al.,
2009; Schewe et al., 2016). To this aim, we administered 3%
DSS in the drinking water to C57BL/6J mice for 1 week and
collected small intestinal crypts to assess their ability to form
organoids on day 3 after withdrawal of DSS; i.e., at the peak of
the regenerative response. As shown in Figure 1F, DSS treat-
ment resulted in a significant increment in organoid multiplicity
(2-fold). Moreover, organoids from DSS-treated mice were
of increased size and more complex morphology (increased
number of budding events) compared with the organoids from
control animals (Figure 1F).
To assess the role of increased SCF expression on the
observed positive effect of DSS-driven inflammation on
intestinal stem cell function, we harvested crypts from DSS-
treated and control mice and supplemented the culture
medium with a soluble c-Kit receptor able to bind andFigure 2. DSS-Induced Intestinal Inflammation Causes Loss of Intestin
(A) FACS analysis of Lgr5+ cells from control or DSS-treated mice 3 days after D
Lgr5-EGFPhigh cells are labeled in green).
(B) Average percentage of Lgr5+ and PCs in control and DSS-treated mice, as qu
shown).
(C) Confocal microscopy images of small intestinal tissues from tamoxifen-treat
mented drinking water for 7 days. Tissues were harvested 3 days after withdraw
(D) Quantification of lineage tracings events in control and DSS-treated Lgr5EGFP
(E) Olfm4 IHC analysis of intestinal tissues from control and DSS-treated mice 1
(F) Quantification of Olfm4+ cells/crypt from control and DSS-treated mice (n = 4
2316 Cell Reports 24, 2312–2328, August 28, 2018sequester SCF, preventing its interaction with its membrane-
bound receptor (Dahlen et al., 2001). In parallel, c-Kit activity
was also repressed by using the receptor tyrosine kinase
inhibitor masitinib (Dubreuil et al., 2009). Although both the
c-Kit receptor and masitinib had no significant effect on
organoids derived from control animals, they substantially
abrogated the increased organoid multiplicity observed in
DSS-treated mice (Figure 1G).
Next we tested whether SCF alone was sufficient to improve
organoid formation. As depicted in Figure 1H, the presence of
SCF in the culturemedium increased the overall number of intes-
tinal organoids as well as the complexity of their morphology
to a very similar degree as that observed in organoids of from
DSS-treated animals (2-fold).
Hence, enhanced SCF expression upon inflammation appears
to play a critical role in the tissue’s regenerative response by
improving intestinal stem cell function.
Lgr5+ Stem Cells Are Depleted upon Inflammation
The observed positive effect of SCF on intestinal stem cell
function in the regenerative response to inflammation raises
the question of whether this is mediated by an increase in self-
renewal and overall multiplicity of Lgr5+ stem cells. To this aim,
we administered 3%DSS to Lgr5EGFP (Lgr5–EGFP–internal ribo-
some entry site (IRES)–CreERT2) (Barker et al., 2007) reporter
mice for 7 days, followed by a 3-day recovery phase, to then
determine Lgr5+ and PC multiplicity by fluorescence-activated
cell sorting (FACS). Notably, Lgr5+ cell multiplicity was severely
decreased in DSS-treated animals (3 fold; Figures 2A, 2B,
S2A, and S2B), indicative of severe loss of intestinal stem cells
upon acute inflammation. No significant change in PC multiplic-
ity was observed upon DSS treatment compared with control
mice (Figures 2B and S2A).
We then compared the lineage tracing ability of Lgr5+ stem
cells between control and DSS-treated mice. To this aim, we
treated Lgr5-EGFP-IRES-CreERT2/R26-lox-stop-lox (LSL)-red
fluorescent protein (RFP) mice with tamoxifen to trigger recom-
bination and lineage tracing from Lgr5+ CBCcells. These animals
were administered 3% DSS for 1 week to then be analyzed
on day 3 after withdrawal of DSS. In line with the FACS data,
confocal microscopy revealed severe loss of Lgr5+ CBC cells
and a severe reduction of Lgr5-derived lineage tracing in the
small intestine of DSS-treated mice (Figures 2C, 2D, and S2B).
Of note, the residual tracing events extend throughout the length
of the crypt villus axis, suggesting that Lgr5+ stem cells that
escape DSS treatment fully retain their self-renewal and differen-
tiation capacity.al Stem Cells
SS withdrawal (FACS plots are representatives of 5 independent experiments;
antified by FACS (**p < 0.01; n.s., not significant; n = 5; mean [SD] values are
ed Lgr5EGFP-IRES-creERT2/R26LSL-RFP mice kept on normal or 3% DSS-supple-
al of DSS.
-IRES-creERT2/R26LSL-RFP mice (n = 3, *p < 0.05; mean [SD] values are shown).
day after removal of DSS.
, *p < 0.05; mean [SD] values are shown).
A B
C
D
E
F
Figure 3. Inflammation Induces Proliferation
and De Novo Organoid Formation from PCs
via Activation of the SCF/c-Kit Signaling Axis
(A) Ki67 IHC analysis of mouse small intestinal tissues
from control and DSS-treated mice 1 day after DSS
removal. Asterisks indicate Ki67-negative PCs in
control mice (left) and Ki67+ PCs in DSS-treated mice
(right) (scale bars, 25 mm (top); bottom, enlarged).
(B) Average percentage of Ki67+ PCs in control and
DSS-treated mice (**p < 0.01, n = 4; mean [SD] values
are shown).
(C) Organoid reconstitution assay of Lgr5+ and PCs
from control and DSS-treated mice (*p < 0.05,
**p < 0.01, n = 3; mean [SD] values are shown).
(D) Pictures showing representative examples of
organoids derived from the reconstitution assays
in (C) on day 7 of culture (scale bars, 100 mm).
(E) Organoid reconstitution assay of untreated and
SCF-treated (50 ng/mL) Lgr5+ and PCs (**p < 0.01,
***p < 0.005, n = 3; mean [SD] values are shown).
(F) Left: organoids derived from PCs of tamoxifen-
injected and DSS-treated LysCreERT2/R26LSL-YFP
mice. Right: organoids derived from SCF-treated PCs
of tamoxifen-injected LysCreERT2/R26LSL-YFP mice.To rule out that DSS-driven inflammation suppresses Lgr5
gene expression without affecting intestinal CBC cells, we per-
formed IHC analysis on intestinal tissues from DSS-treated
mice with an antibody directed against the Olfm4 protein, whose
expression overlaps with that of Lgr5 (van der Flier et al., 2009a).
As shown in Figures 2E, 2F, and S2C, a significant reduction in
Olfm4+ cells is evident in intestinal crypts from DSS-treated
animals, especially at the crypt base, where they normally are
intermingled with PCs.
Altogether, these results demonstrate that acute inflammation
causes severe loss of intestinal stem cells, which are conse-
quently no longer capable of contributing to the regenerative
response to tissue damage.
PCs Underlie Enhanced Intestinal Stem Cell Function
upon Inflammation
The loss of Lgr5+ stem cells upon acute inflammation is in sharp
contrast with the positive effect exerted by DSS on intestinal
stem cell function, as shown by organoid assays. To assess
whether any de novo proliferating cell type is detectable in the in-Cell Rtestinal crypt upon inflammation, we per-
formed Ki67 staining on small intestinal tis-
sue from DSS-treated and control mice. In
the latter, Ki67 expression is restricted to
the slender CBC cells (Lgr5+) cells at the
bottom of the crypt and the transient ampli-
fying compartment, whereas the post-
mitotic PCs are negative (Figure 3A, left). In
DSS-treated mice however, apart from the
absence of cells morphologically similar to
CBC cells, the granulated PCs are Ki67-
positive (Figure 3A, right). We confirmed
the PC identity of these Ki67+ cells by
confocal microscopy; lysozyme/Ki67 dou-ble-positive cells are present in the intestinal crypts of DSS-
treated mice (Figure S3A). Quantification of the number of crypts
encompassing Ki67+ PCs (>30%) highlights the relatively high
frequency of reacquisition of proliferative capacity by PCs
upon tissue damage (Figure 3B). Notably, Ki67+ PCs could
also be detected in the inflamed ileal tissues of CD patients (Fig-
ure S3B; 2 of 4).
In view of these and previous results (Roth et al., 2012), we ad-
dressed the functional role played by these secretory cells in the
regenerative response of the intestinal stem cell niche to the in-
flammatory insult. To this aim, the organoid reconstitution assay
(ORA) was employed (Sato et al., 2011; Schewe et al., 2016,
2017; Yilmaz et al., 2012). Here, Lgr5+ and PCs are sorted by
FACS from control and DSS-treated Lgr5EGFP mice (3 days after
DSS treatment; i.e., when de novo Lgr5+ cells are not yet
observed) to then be reconstituted in different combinations to
form intestinal organoids (Figures 3C and 3D). As expected,
reconstitution of Lgr5+ with PCs from control mice led to the for-
mation of organoids, whereas neither Lgr5+ nor PCs alone were
able to form organoids. Reconstitution of Lgr5+ and PCs fromeports 24, 2312–2328, August 28, 2018 2317
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DSS-treated mice resulted in a significant increase in organoid
numbers, similar to the effect of DSS on organoid formation
from whole intestinal crypts. Reconstitution of Lgr5+ cells from
DSS-treated mice with PCs from controls did not differ in orga-
noids numbers from the control (both cell types from untreated
mice), suggesting that the stem cell function of the residual
Lgr5+ cells, as also observed in vivo (Figure 2C), is unaffected.
Last, PCs from DSS-treated mice reconstituted with control
Lgr5+ stem cells resulted in a significant increase in organoid
multiplicity compared with the reconstitution of control Lgr5+
and PCs. Of note, the number of organoids generated when con-
trol Lgr5+ cells were reconstituted with PCs from DSS-treated
mice was very similar to the organoid multiplicity observed
when both lineages were obtained from DSS-treated mice
(p = 0.15). This indicates that the enhanced stem cell function
elicited by inflammation is influenced by PCs, possibly through
their previously reported niche role in support of Lgr5+ stem cells
(Sato et al., 2011). However, the observed proliferative response
of PCs to inflammation suggests alternative scenarios where
the post-mitotic secretory cells directly contribute to tissue
regeneration by de-differentiation and acquisition of stem cell
features. Indeed, PCs from DSS-treated mice were able to
form organoids autonomously (i.e., in the absence of Lgr5+ cells)
(Figures 3C and 3D).
Next we took advantage of the ORA by exposing Paneth (and
Lgr5+) cells sorted from control mice to recombinant SCF
prior to their reconstitution in different combinations (Figure 3E).
As expected, untreated Lgr5+ cells or PCs gave rise to very low
numbers of organoids when plated alone. The latter was also
true for Lgr5+ cells pretreated with SCF. However, SCF treat-
ment of PCs resulted in a striking increase in organoidmultiplicity
(approximately 10-fold). Accordingly, reconstitution of SCF-
treated Lgr5+ cells with untreated PCs did not affect the number
of organoids compared with the controls. Instead, SCF-treated
PCs gave rise to the highest organoid multiplicity when reconsti-
tuted with untreated Lgr5+ cells (Figure 3E).
To provide definitive evidence of the PC origin of these orga-
noids, we repeated the DSS treatments and organoid experi-
ments using LysCreERT2/R26LSL-YFP mice and YFP+ PCs isolated
during the regenerative phase. The resulting organoids were
entirely composed of YFP+ cells, confirming that, upon inflam-
mation, PCs acquire stem cell features and give rise to mini-
gut structures ex vivo (Figure 3F, left). Also in the case of SCF
treatment, we repeated the experiment with PCs from tamox-
ifen-treated LysCreERT2/R26LSL-YFP mice and confirmed that the
organoids are entirely composed of YFP+ cells (Figure 3F, right).
To demonstrate that PCs can also act in vivo as stem cells in
response to inflammation, we administered DSS to LysCreERT2/
R26LSL-YFP mice and analyzed their small intestine for lineage
tracing events at several time points after withdrawal of DSS.Figure 4. PCs De-differentiate into Stem-like Cells in Response to DSS
(A) Lineage tracing analysis of tamoxifen-injected LysCreERT2/R26LSL-YFP mice at
(B) Ki67 expression analysis of LysCreERT2/R26LSL-YFP mice 1 day after DSS withd
(C) Analysis of lysozyme expression in LysCreERT2/R26LSL-YFP mice 7 days after D
(D) Analysis of Olfm4 expression in LysCreERT2/R26LSL-YFP mice 7 days after DSS
(E) Analysis of expression of differentiationmarkers (goblet cells, Muc2; entero-end
DSS withdrawal (scale bars, 100 mm).In tamoxifen-treated control mice, yellow fluorescent protein
(YFP) fluorescence was entirely restricted to PCs located at
the crypt base (Figures 4A and 4C). However, FACS analysis
of tamoxifen-treated LysCreERT2/R26LSL-YFP mice revealed that
only a small proportion (12%) of PCs express YFP after
3 consecutive injections of tamoxifen (2 mg/20 g body weight/
day) (Figures S4A, top, and S4B). Nonetheless, virtually all
(97%) of the YFP+ cells were confirmed to be PCs by FACS (Fig-
ures S4B, bottom, and S4D). All YFP+ cells were positive for c-Kit
and lysozyme (Figure S4C). No YFP signal was detected prior to
tamoxifen administration (Figure S4D). In DSS-treated (and
tamoxifen-treated) animals, the YFP signal was still restricted
to PCs at the crypt base 1 day after DSS removal (Figure S4E).
However, already at this time point, a proportion of the YFP+ cells
started to show nuclear Ki67, indicative of cell cycle re-activation
in PCs (Figure 4B). Three days after DSS removal, short ribbons
of YFP+ cells were observed within the intestinal crypts. Seven
days after removal of DSS, YFP stained approximately
50%–70% of the crypt-villus axis and reached the tip of the villi
on day 10 (Figure 4A). These in vivo results demonstrate that,
upon DSS-driven acute inflammation, PCs acquire stem cell
features and repopulate the intestinal epithelium, contributing
to the tissue-regenerative response.
To assess the multipotency of the Paneth-derived stem cells,
we carried out immunofluorescence (IF) analysis with lineage-
specific markers of the YFP+ ribbons from DSS-treated
LysCreERT2/R26LSL-YFP mice on day 7 of the recovery phase. As
shown in Figure 4D, YFP+ cells located at the bottom of the crypt
co-expressed Olfm4, indicating that new CBC cells are gener-
ated from lysozyme-expressing PCs. As for the YFP+ cells
located above the crypt base and along the villus axis, expres-
sion of entero-endocrine (chromogranin A+ [ChrA+]/YFP+),
goblet (Muc2+/YFP+), and tuft (Dclk1+/YFP+) lineage-specific
markers was detected (Figure 4E). Hence, the Paneth-derived
stem cells give rise to ribbons that recapitulate both the crypt-
villus architecture and heterogeneous cell lineage composition
of the intestinal epithelium.
Taken together, our results show that, upon acute inflamma-
tion PCs de-differentiate into proliferating stem-like cells able
to form 3D organoids ex vivo and to repopulate in vivo the epithe-
lial lining, giving rise to stem cells as well as all of the differenti-
ated lineages of the adult intestinal epithelium. Activation of the
SCF/c-Kit signaling pathway plays a central role in acquisition
of stem-like features by PCs upon inflammation.
Activation of the SCF/c-Kit Signaling Axis and of the
Downstream PI3K/Akt and Wnt Pathways Elicits
Stemness in PCs upon Inflammation
SCF/c-Kit signaling has been shown to activate several
downstream signaling pathways (Lennartsson and Ro¨nnstrand,-Induced Inflammation
several time points after DSS treatment (scale bars, 100 mm).
rawal (scale bar, 25 mm).
SS withdrawal (scale bars, 25 mm).
withdrawal (scale bars, 25 mm).
ocrine cells, ChrA; tuft cells, DCLK1) in LysCreERT2/R26LSL-YFPmice 7 days after
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Figure 5. SCF Triggers PC De-differentiation
via the PI3K/AKT Signaling Axis
(A) IF analysis of pAkt in untreated and SCF-treated
(50 ng/mL) intestinal crypts from Lgr5-EGFP mice
(arrows indicate pAkt+ PCs; scale bar, 25 mm). In-
testinal crypts were counterstained with DAPI and
phalloidin. The picture shows one representative
example from at least 3 independent experiments.
(B) Western blot analysis of untreated and SCF-
treated (50 ng/mL) Lgr5+ and PCs using antibodies
against c-Kit, pAkt, total Akt, GFP, and actin.
(C) Quantification of pAkt/Akt signal intensity from
the western blot in (B) (*p < 0.05, n = 3; mean [SD]
values are shown).
(D) Organoid reconstitution assay of Lgr5+ and PCs
from control and DSS-treatedmice. PCswere either
left untreated or treated with BKM120 (PI3K inhibi-
tor, 1 mM) or AKTVIII (Akt inhibitor, 4 mM) (*p < 0.05,
**p < 0.01, n = 3; mean [SD] values are shown).
(E) Representative pictures of PC-derived organo-
ids as described in (D) (scale bars, 50 mm).
(F) RNA-seq analysis of PCs from control (n = 3) and
DSS-treated (n = 4) mice 3 days after DSS with-
drawal. Heatmaps show differentially expressed
genes (left, Wnt target genes; center, lysozymes and
alpha-defensins; right, cell proliferation marker
genes). Color codes indicate average Z scores of
each condition.2012). To assess which of these pathways may play a role in
the observed de-differentiation and acquisition of stem-like fea-
tures in PCs upon inflammation and the consequent SCF/c-Kit
signaling activation, we treated whole small intestinal crypts
with SCF in combination with several inhibitors of known down-
stream pathways, such as mitogen-activated protein kinase
(MAPK), mechanistic target of rapamycin (mTor), PI3K/Akt and
Jak/Stat signaling, and tested their capacity to form organoids
(Figure S5A). As shown before, SCF treatment alone significantly
increased organoid multiplicity compared with untreated crypts.
MAPK signaling inhibition completely repressed organoid
growth both in the presence or absence of SCF, indicating an
essential role for this pathway in organoid growth independent
of the activation of the SCF/c-Kit signaling axis. In contrast, the
mTOR inhibitor rapamycin did not affect organoid multiplicity
with or without SCF. Inhibition of Jak1 instead increased
organoid numbers to the same extent both in the absence and
presence of SCF. Of the 4 main downstream pathways tested,2320 Cell Reports 24, 2312–2328, August 28, 2018only the inhibition of PI3K/Akt signaling
completely and specifically abrogated the
positive effects exerted by SCF on orga-
noid growth (Figure S5A).
To establish whether SCF activates
PI3K/Akt signaling in PCs, whole intestinal
crypts from Lgr5EGFP mice were treated
with SCF and analyzed by IF with anti-
bodies directed against pan- and phos-
phorylated Akt (pAkt). Although Akt was
expressed in all cell types of the intestinal
crypt (Figure S5B), Akt phosphorylation
was exclusively observed in PCs uponSCF stimulation (Figures 5A and S5C). Western blot analysis of
PCs sorted by FACS and incubated with SCF confirmed the
increased pAkt levels in the secretory cells. In contrast, analysis
of the c-Kit negative Lgr5+ stem cells did not reveal any change
(Figures 5B and 5C).
To assess the relevance of the role playedbyPI3K/Akt signaling
in the response to inflammation, PCs were sorted from DSS-
treated mice and cultured to generate organoids in the presence
of specific PI3K (BKM120;Wen et al., 2012) and Akt (AKTVIII; Bar-
nett et al., 2005) inhibitors. In confirmation of the above result with
whole intestinal crypts, both PI3K as well as Akt inhibition signifi-
cantly reduced the number of organoids obtained fromPCs alone
(Figures 5D and 5E). Likewise, in reconstitution assays, inhibition
of PI3K or Akt in PCs significantly repressed organoid growth
when Lgr5+ and PCs from DSS-treated mice were employed,
although not ones from untreated mice (Figure 5D).
To evaluate the global effects of acute inflammation on PCs,
we performed RNA expression analysis by next-generation
AF
G
D
H I
B
C E
Figure 6. Activation of the SCF/c-Kit Signaling Axis Inhibits Gsk3b and Activates Wnt in PCs
(A) IF analysis of phospho-GSK3b in untreated and SCF-treated intestinal crypts from Lgr5-EGFP mice. Arrows indicate phospho-GSK3b-negative PCs in
untreated crypts (top). Among SCF-treated crypts (bottom), phospho-GSK3b PCs become evident (also indicated by arrows; scale bars, 25 mm). Intestinal crypts
were counterstained with DAPI and phalloidin. The picture shows one representative example of at least 3 independent experiments.
(B) Relative fluorescence intensity of phospho-GSK3b in PCs treated as described in (B). PCs were set as ROI (region of interest) for the measurement of
phospho-GSK3b intensity (*p < 0.05, n = 3; mean [SD] values are shown).
(legend continued on next page)
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sequencing (NGS) RNA sequencing (RNA-seq) on sorted cells
from control and DSS-treatedmice. In agreement with the in vivo
data, the RNA-seq results revealed upregulation of genes related
to cell proliferation and the cell cycle and downregulation of
PC-specific markers such as lysozymes and defensins (Fig-
ure 5F). Of note, a group of genes known to earmark infrequently
dividing and quiescent stem cells (i.e., Tert, Ascl2, EphB2,
Dclk1, and Lrig1; Figure S5D) were upregulated in PCs from
DSS-treated mice, whereas the expression of other stem cell
markers, such as Lgr5,Bmi1, andHopx, appeared to be reduced
(Figure S5D).
Last, pathway analysis performed on the differentially ex-
pressed genes pointed to activation of the canonical Wnt
signaling pathway, as shown by the upregulation of several
Wnt target genes (Figure 5F). This is likely to be related to the
observed role played by PI3K/Akt signaling downstream of
SCF/cKit; it has been shown that PI3K/Akt activation can in-
crease Wnt signaling activity through GSK3b inhibitory phos-
phorylation at Ser-9 (Doble and Woodgett, 2003). IF analysis of
whole-mount intestinal crypts revealed that, as for Akt, GSK3b
is expressed in all epithelial cells (Figure S6A). In these control
crypts, Lgr5+ stem cells as well as the proliferative transient
amplifying (TA) compartment express high levels of phosphory-
lated GSK3b as a result of Wnt signaling activation in these line-
ages (Figure 6A). In contrast, PCs appear to be negative for
pGSK3b, notwithstanding their characteristic nuclear b-catenin
localization (van Es et al., 2005). However, upon SCF treatment,
an increase in GSK3b phosphorylation in PCs becomes evident
(Figures 6A and 6B). Western blot analysis of sorted Lgr5+ and
PCs confirmed the increased GSK3b phosphorylation in PCs,
although not in CBC cells, upon DSS treatment (Figures 6C
and 6D).
GSK3b inhibitory phosphorylation in SCF-treated PCs is ex-
pected to inhibit b-catenin proteolytic degradation, leading to
its cytoplasmic accumulation and translocation into the nucleus,
where it acts as a co-transcriptional factor to activate expression
of Wnt target genes. To validate the ability of SCF to increase
Wnt signaling even in already Wnt-active cells, the TOPflash/
FOPflash (TOP/FOP) Wnt reporter gene assay was implemented
in the colon cancer cell line CaCo2. Supplementation of the cul-
ture medium with recombinant SCF significantly enhanced Wnt
signaling in this APC mutant cell line (Figure 6E). To validate
that SCF can also activate Wnt signaling in PCs, qRT-PCR anal-
ysis of specific Wnt target genes was performed on sorted PCs
treated with SCF. In line with the results of the reporter gene
assay and in confirmation of the RNA-seq data fromDSS-treated(C) Western blot analysis of untreated and SCF-treated (50 ng/mL) Lgr5+ and PC
and actin.
(D) Quantification of phospho-GSK3b/GSK3b signal intensity in the western blot
(E) TOP-Flash luciferase reporter assay of control and SCF-treated (50 ng/mL) C
(F) qRT-PCR analysis of control and SCF-treated (50 ng/mL) PCs using primer sets
mean [SD] values are shown).
(G) b-Catenin IHC analysis of intestinal tissues from control and 3% DSS-treated
cytoplasmic b-catenin; scale bars, 25 mm). Pictures show representative exampl
(H) Number of organoids derived from control or Chiron-treated (10 mM) Lgr5+ or
(I) Representative pictures of organoids derived from control and Chiron-treated
organoids. Center: Chiron-treated Lgr5+ and PCs generate enterospheres. Right
2322 Cell Reports 24, 2312–2328, August 28, 2018mice, upregulation of Axin2, Jun, and Ccdn1 (cyclin D1) was
found in SCF-treated PCs (Figure 6F).
To confirm that inflammation enhances Wnt signaling in PCs
in vivo, we analyzed by IHC their intracellular b-catenin distribu-
tion. As expected, nuclear b-catenin was observed in PCs
from control animals with hardly any cytoplasmic staining. In
contrast, PCs from DSS-treated mice showed a clear increase
in cytoplasmic b-catenin, indicative of its increased stability
and, consequentially, of enhanced Wnt signaling (Figure 6G).
Because PC differentiation is known to be driven by Wnt (van
Es et al., 2005), the functional consequences of its further activa-
tion downstream of the SCF/c-Kit signaling axis in a cell type
already earmarked by nuclear b-catenin in the context of the
regenerative response to inflammation are still unclear. To eluci-
date this aspect, we employed CHIR99021 (Chiron), a potent
and selective GSK3b inhibitor leading to robust Wnt signaling
activation, in organoid assays. As shown in Figures 6H and 6I,
upon Chiron supplementation in the culture medium, PCs from
control animals gave rise to high organoid numbers. As ex-
pected, Chiron treatment had a similar effect on Lgr5+ CBC cells.
Of note, although a majority of enterospheres (i.e., spherical
structures primarily composed of stem cells and lacking budding
and branching structures; Stelzner et al., 2012) were observed
during the early phase of the culture, upon Chiron withdrawal,
differentiation occurred, and ‘‘normal’’ organoid morphologies
were observed both from PCs and Lgr5+ cells (Figure 6I). Indeed,
conversion between enterospheres and organoids has been
shown to be regulated by Wnt signaling (Fordham et al., 2013;
Mustata et al., 2013).
As shown previously (Figures 1D and 1E), mice treated with
both DSS and ISCK03 suffered from increased loss of body
weight and an overall decrease in DAI scores compared with an-
imals treated with DSS alone. To assess whether this deleterious
effect parallels the lack ofWnt ‘‘super-activation’’ downstreamof
the SCF/cKit signaling axis, b-catenin IHC analysis was again
performed in small intestinal tissues from mice treated with
DSS alone or in the presence of the ISCK03 inhibitor. As shown
in Figure 7A, DSS treatment alone causes enhanced b-catenin
accumulation in the cytoplasm and nucleus of PCs, indicative
of increased Wnt signaling activation. This effect is almost
entirely abrogated in mice treated simultaneously with both
DSS and ISCK03. Furthermore, ISCK03 significantly reduced
the number of Ki67+ PCs in DSS-treated mice (Figures 7B and
7C and S7A). Accordingly, combined DSS/ISCK03 treatment
of Lyz-Cre/YFP mice strongly compromised the ability of PCs
to lineage-trace upon inflammation (Figures 7D and 7E).s using antibodies directed against c-Kit, phospho-GSK3b, total GSK3b, GFP,
shown in (C) (*p < 0.05, n = 3; mean [SD] values are shown).
aCo2 cells (*p < 0.05, n = 3; mean [SD] values are shown).
specific for theWnt target genes Axin2, c-Jun, and Cyclin D1 (**p < 0.01, n = 3;
(7 days) mice 1 day after DSS withdrawal (arrows indicate PCs with increased
es of crypts from 3 independent mouse experiments.
PCs sorted by FACS (***p < 0.005, n = 3; mean [SD] values are shown).
(10 mM) Lgr5+ or PCs sorted by FACS. Left: untreated cells did not give rise to
: upon Chiron withdrawal, enterospheres give rise to differentiated enteroids.
Figure 7. SCF/c-Kit Signaling Inhibition Counteracts DSS-Induced Wnt Activation and PC De-differentiation
(A) b-Catenin IHC analysis of intestinal tissues from control and DSS-, ISCK03-, or DSS + ISCK03-treated mice 1 day after stop of treatment (arrows indicate PCs
with increased cytoplasmic b-catenin; scale bar, 25 mm). Pictures show representative examples of crypts from 3 independent mice.
(B) Ki67 immunohistochemistry analysis of intestinal tissues from control and DSS-, ISCK03-, or DSS + ISCK03-treatedmice 1 day after stop of treatment (arrows
indicate Ki67-expressing PCs; scale bars, 25 mm). Pictures show representative examples of crypts from 3 independent mice.
(legend continued on next page)
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Taken together, these results show that inhibition of the SCF/
c-Kit signaling axis prevents downstream Wnt signaling activa-
tion in PCs, compromising their capacity to acquire stem-like
feature and to contribute to the regenerative response of the in-
testinal epithelium to the inflammatory insult.
DISCUSSION
IBD is regarded as an emerging global ailment in view of its
steadily rising incidence during the last decades (M’Koma,
2013). Apart from its profound negative effects on the patient’s
quality of life, IBD is associated with an increased risk of devel-
oping intestinal cancer (Itzkowitz and Yio, 2004; Jia et al.,
2008; Rosen and Jordan, 2009). From this perspective, the eluci-
dation of the cellular and molecular mechanisms underlying the
regenerative response of the intestinal stem cell niche to inflam-
matory tissue damage is of fundamental and translational rele-
vance. Because of the complexity of the tissue response to injury
and in view of the fact that IBD syndromes such as UC and CD
affect different segments of the digestive tract, we have here
chosen to model intestinal inflammation in the mouse through
DSS administration in the drinking water (Elsheikh et al., 2012).
The mucosal injury caused by DSS results in acute inflammation
of the entire gastrointestinal (GI) tract (pan-gastroenteritis)
through recruitment and activation of inflammatory cells, fol-
lowed by a rapid tissue regeneration phase (Vowinkel et al.,
2004), providing a useful preclinical in vivo inflammation model
for both UC and CD. Although many other experimental (i.e., ge-
netic) models for IBD exist that possibly better reflect the im-
mune features of CD and UC, our choice for the DSS model is
based on the similar predisposition of these mice to intestinal
cancer, as observed in IBD (of high relevance when it comes to
the stem cell origin of cancer), and by the ease and suitability
of DSS administration to study the primary regenerative
response of the stem cell niche to the tissue insult. Therefore,
it does represent an ideal model to perform PC lineage tracing
upon the primary inflammatory stimulus.
Enhanced secretion of the SCF has been reported in the
plasma of IBD patients (Andersson et al., 2017; Comar et al.,
2012) and confirmed here both in the intestinal epithelium and
underlying stroma of UC and CD patients and in the DSS mouse
model. This is of interest in view of the specific expression of the
SCF transmembrane receptor c-Kit in PCs and their equivalent in
the colon (Rothenberg et al., 2012). Increased SCF expression
was also observed in intestinal epithelial cells in response to
cholera toxin or Salmonella enterica Typhimurium infection
(Klimpel et al., 1995, 1996). SCF/c-Kit signaling is a major regu-
lator of proliferation and differentiation in the hematopoietic sys-
tem (Broudy, 1997). Mast cells and dendritic cells express high
c-Kit levels even when fully differentiated but retain the capacity
to re-enter the cell cycle in response to extracellular SCF stimu-
lation (Metcalfe et al., 1997; Ray et al., 2010). Besides, functional(C) Quantification of the percentage of crypts with Ki67+ PC in intestinal tissues o
mean [SD] values are shown).
(D) Lineage tracing analysis of tamoxifen-injected Lyz-Cre-R26-LSL-YFP mice (
analyzed 7 days after removal of DSS (scale bars, 100 mm).
(E) Quantification of PC lineage tracing events of the mice described in (D) (n = 4
2324 Cell Reports 24, 2312–2328, August 28, 2018analysis of the response of PCs to SCF, as shown here, is of
broader interest, as indicated by the role played by SCF expres-
sion from differentiated tumor cells in the maintenance of c-Kit-
expressing colon cancer stem cells (Fatrai et al., 2015).
We here show that severe loss of Lgr5+ CBC cells character-
izes the primary response to DSS-driven inflammation. Targeted
ablation of Lgr5+ stem cells in the mouse intestinal epithelium
showed that these cells are, in fact, dispensable and that their
role is taken over by their quiescent counterparts (Tian et al.,
2011; van der Flier et al., 2009b). Depletion of Lgr5+ stem cells
has also previously been reported in the colon of DSS-treated
mice, where they reappear on day 5 of the recovery phase to
then reach normal levels 1 day thereafter (Davidson et al.,
2012). Similarly, loss of Lgr5+ CBC cells has been observed
upon high-dose g-irradiation (Yan et al., 2012). In both cases,
the depletion is temporary, and the CBC cell pool at the base
of the crypt is rapidly restored.
More persistent CBC cell loss upon tissue injury is compen-
sated by the regenerative response of alternative stem cell pools,
including the infrequently cycling Bmi1+ stem cells at position +4
(Sangiorgi and Capecchi, 2008; Yan et al., 2012) and secretory
(Dll1+) (van Es et al., 2012) and enterocyte (Alpi+) (Tetteh et al.,
2016) progenitors in addition to label retaining cells (LRCs) ex-
pressing PC markers (Buczacki et al., 2013; Roth et al., 2012),
capable of reacquiring proliferative and self-renewal cell capac-
ity upon tissue injury or targetedCBC cell ablation. Therefore, the
intestinal epithelium shows remarkable plasticity, with several
stem and progenitors cell types contributing to the restoration
of tissue integrity and re-establishment of the actively cycling
Lgr5+ CBC cells (Yousefi et al., 2017). However, the ablation
and tissue injury protocols employed in these studies are not
directly relevant for IBD and the tissue damage caused by
inflammation. Also, it is not clear whether the plasticity of the in-
testinal epithelium, apart from the above stem and progenitor
cells, also extends to more committed and even post-mitotic lin-
eages. Here we show that, following the initial loss of Lgr5+ CBC
cells, the response to acute inflammation features fully differen-
tiated PCs capable of re-entering the cell cycle, losing their
secretory features, and acquiring self-renewal and pluripotency,
contributing to the repair and regeneration of the damaged intes-
tinal tissue.
As mentioned above, the specific expression of the c-Kit re-
ceptor in PCs and in their counterparts in the colon (Rothenberg
et al., 2012; Schewe et al., 2016) and the increased secretion of
its natural ligand SCF upon inflammation both in IBD patients
and in the DSS mouse model are of functional relevance for
cell cycle re-entry, dedifferentiation, and acquisition of stem
cell properties by these mature and normally post-mitotic secre-
tory cells. Stimulation of the SCF/c-Kit signaling axis results in a
cascade of downstream events from PI3/Akt pathway activation
to GSK3b inhibitory phosphorylation. Of note, PI3K/Akt activa-
tion upon SCF/c-kit signaling induction has been shown tof control, DSS-, and DSS + ISCK03-treated mice (*p < 0.05, ***p < 0.005, n = 3;
left, control; center, DSS; right, DSS + ISCK03). Tissues were harvested and
, *p < 0.05; mean [SD] values are shown).
promote cell proliferation, growth, and survival in several
models, including colon cancer cell lines (Jeon et al., 2009; Vaj-
ravelu et al., 2015; Yasuda et al., 2007). Among the many pleio-
tropic effects of GSK3b inhibition, Wnt/b-catenin signaling acti-
vation is likely to play a central role in conferring proliferative
and stem-like features to PCs, as observed here. However, it
is well- established that Wnt signaling also underlies PC differ-
entiation (van Es et al., 2005) and is retained in mature secretory
cells, as indicated by their characteristic nuclear b-catenin
staining. Distinct Wnt signaling dosages are associated with
different downstream target genes and stem cell differentiation
outcomes, as shown previously by our laboratory (Gaspar and
Fodde, 2004; Kielman et al., 2002). Moreover, ectopic activation
of canonical Wnt signaling has been shown to be essential for
the quiescence exit ofmTert+ stem cells as well as for Dll1+ pro-
genitors to regain stemness (Montgomery et al., 2011; van Es
et al., 2012). Indeed, ex vivo enhancement of Wnt signaling in
PCs by GSK3b inhibition results in de novo organoid formation,
highlighting the central role of the super-activation of this
pathway downstream the SCF/c-Kit axis in the de-differentia-
tion and cell cycle re-entry of secretory cells during tissue
regeneration. Nonetheless, in view of the pleiotropic effects of
Gsk3b inhibition on a broad spectrum of downstream signaling
cascades, it is likely that other pathways synergize with Wnt
in inducing PC dedifferentiation upon SCF/c-Kit activation.
Recently, Yu et al. (2018) published a study confirming our orig-
inal observations according to which PCs de-differentiate upon
whole-body irradiation (12 Gy) (Roth et al., 2012). Of note, acti-
vation of Notch signaling, but not Wnt, seems to characterize
the acquisition of stem-like features by PCs. In our RNA-seq
analysis of PCs from DSS-treated mice, only very few of the
differentially upregulated genes are indeed indicative of
increased Notch signaling. Of the 12 genes reported in the study
by Yu et al. (2018) as upregulated in PCs upon high-dose irradi-
ation, only 4 (Notch1, Dtx4, Hes1, and Rps19) were significantly
upregulated in our data. In view of the fact that Hes1 has previ-
ously been reported as a Wnt target and Notch1 as an activator
of the Wnt pathway (Collu et al., 2014), it is likely that the well-
established cross-talk between these two signaling pathways
also comes into play upon inflammation. Nonetheless, it ap-
pears that Wnt signaling activation downstream of SCF/c-Kit
and Gsk3b inhibition plays a central role in the observed de-dif-
ferentiation of PCs upon inflammation, as functionally validated
by several independent experimental approaches. Interestingly,
Yu et al. (2018) employed an inducible mutant b-catenin allele to
confirm that activation of Wnt did not play a central role in the
dedifferentiation of PCs. However, this mutant allele is a potent
oncogene resulting in extremely high Wnt signaling levels, the
dosage of which may not be ‘‘just right’’ for the acquisition of
stem-like features by PCs (Gaspar and Fodde, 2004). As
mentioned above, it is plausible that, in view of the pleiotropic
effects of Gsk3b inhibition, several other signaling pathways,
including Notch, are activated and synergize with Wnt in this
process.
The regenerative capacity of PCs is maintained ex vivo, as
shown by their capacity to form small intestinal organoids
when isolated from DSS-treated mice (or upon SCF stimulation)
in the absence of Lgr5+ CBC cells. Thus, PCs represent an addi-tional pool of reserve stem cells capable of contributing to tissue
regeneration upon injury. However, in view of their role in sup-
porting Lgr5+ CBC cells (Sato et al., 2011), it is also plausible
that inflammatory cues may enhance their niche function next
to expansion of the stem cell pool. Although ex vivo reconstitu-
tion of PCs from DSS-treated animals with Lgr5+ CBC cells
from control mice resulted in a marked increase in organoid mul-
tiplicity, analysis of their expression profiles did not reveal a sig-
nificant increase in the expression of niche signals (e.g., EGF,
transforming growth factor [TGF], Wnt3, or Dll4; data not shown)
usually provided by PCs tomaintain stemness of CBC cells (Sato
et al., 2011). Nevertheless, inflammation is likely to exert
context-dependent effects in the small and large intestine.
Indeed, SCF was found among the proteins shown previously
to be present at significantly different abundances between
UC and CD (Andersson et al., 2017). PC metaplasia (i.e., the
appearance of PCs in the colon, where they normally do not
belong; Paterson and Watson, 1961), is frequently observed
among UC patients and may result from differentiation of
c-Kit+ cells to provide further niche support to stem cells in
response to inflammation. On the other end, metaplastic PCs
have also been observed in colon adenomas and carcinomas
(Lewin, 1968; Wada et al., 1992) and have been proposed to
represent important precursors of IBD-associated colon cancer
(Wada, 2009; Wada et al., 2005). Hence, the regenerative
response to inflammatory tissue damage may differ between
the small intestine and colon and reflect the distinct predisposi-
tion to bowel cancer among IBD patients. Lineage tracing of the
c-Kit+ Paneth-like cells of the colon upon DSS administration will
likely clarify this aspect.
The presence of multiple and distinct pools of low-cycling
stem cells in the intestinal epithelium raises the issue of their in-
dividual roles and relative contributions to tissue regeneration
upon inflammation. Two studies showed that PC depletion
does not have major consequences and, therefore, may be
dispensable in intestinal tissue homeostasis and regeneration
(Durand et al., 2012; Garabedian et al., 1997). However, it is un-
clear whether the ablation of PCs in these mouse models is
limited to fully mature cells because their secretory precursors
may compensate for the loss of niche and stem cell functions.
Also, these depletion models have not been challenged by
inflammation. In support of their essential role, other studies
demonstrated that PCs are critical to provide niche support
and maintain the Lgr5+ stem cell population during crypt regen-
eration (Geiser et al., 2012; Parry et al., 2013; Sato et al., 2011).
Given these rather controversial observations, future studies
should focus on the role of PCs in ensuring intestinal tissue integ-
rity, particularly in the context of inflammation. Notably, inhibition
of SCF/c-Kit signaling resulted in increased weight loss and DAI
upon inflammation, likely to result at least partially from the pre-
vention of PCs to take part in intestinal tissue repair. However,
because c-Kit is expressed in other cell types regulating inflam-
matory responses, such as mast, dendritic, and interstitial cells
of Cajal (Miettinen and Lasota, 2005), further studies are required
to reveal the specific role of c-Kit inhibition of PCs in the
response to inflammation.
In conclusion, we show that activation of the SCF/c-Kit
signaling axis upon inflammation induces cell cycle re-entry,Cell Reports 24, 2312–2328, August 28, 2018 2325
dedifferentiation, and acquisition of stem cell properties in PCs
by enhancing Wnt through PI3K/Akt activation and GSK3b inhi-
bition. Therefore, beside their role as regulators of the intestinal
microflora and as niche cells for actively cycling CBC cells,
PCs serve as a pool of quiescent stem cells that can be reacti-
vated upon tissue insults and contribute to tissue regeneration.
The diversity and complexity of their functional roles in IBD,
dysbiosis, and cancer make Paneth(-like) cells in the small
bowel and colon a central node for intestinal homeostasis and
diseases.
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Fiji software N/A https://fiji.sc/CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagentsmay be directed to andwill be fulfilled by the LeadContact, Riccardo Fodde at Erasmus
Medical Center Rotterdam, Email: R.Fodde@erasmusmc.nl.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
All mice employed in this study were aged between 8-12weeks of age, fed ad libitum, andmaintained on a 12-hour light/dark cycle at
the Erasmus MC animal facility (EDC) and the IPMC animal facility under conventional SPF conditions. Inbred C57BL/6J mice were
fromCharles River Laboratories. Lgr5EGFP-IRES-creERT2,R26LSL-YFP andR26LSL-tdTomato mice were from Jackson laboratories. All mice
used in this study were on a C57BL/6J background.
The generation and characterization of the LysCreERT2/R26LSL-YFP model will be described elsewhere (J.v.E., unpublished data). In
short: the pLysCreERT2 mouse model was generated through homologous recombination in IB10 embryonic stem cells (129/Ola). The
CreERT2 gene was knocked onto the ATG start codon of the of the lysozyme (Lys) gene. Both flanking arms were generated by high-
fidelity PCR reactions from male 129/Ola-derived BAC DNA and subsequently cloned into PL451. The targeting construct (100 mg)
was linearized and transfected into male 129/Ola-derived IB10 embryonic stem cells by electroporation (800V, 3F). Recombinant ES
cell clones expressing the neomycin gene were selected in medium supplemented with G418 (250 mg/ml). Recombinant embryonic
stem cell clones were screened by Southern blotting. The frequency of homologous recombination was 4%. Two positive clones
were selected and injected into C57BL/6 derived blastocysts using standard procedures. Both injected clones gave germline trans-
mission. The neomycin selection cassette was flanked by Frt recombination sites and excised in vivo by crossing the mice with the
general FLP deleter strain (Jackson Lab.). LysCreERT2 mice were then crossed with R26LSL-YFP mice (R26R-YFP, #006148, Jackson
Lab). All procedures were approved by local (ErasmusMC ‘‘Instantie voor Dierenwelzijn’’ and ‘‘Dierenexperimentencommissie’’) and
national (Centrale Commissie Dierproeven) review and performed in agreement with local animal welfare laws and guidelines.
METHOD DETAILS
Tamoxifen administration
To activate C-recombinase, Lgr5EGFP-IRES-creERT2/R26LSL-RFP mice were intraperitoneally (i.p) injected once with 1mg/20 g body-
weight of Tamoxifen (Sigma); the LysCreERT2/R26LSL-YFP were i.p. injected three times on consecutive days with 1 mg/20 g body
weight. Tamoxifen was dissolved in 100% Ethanol (stock concentration 200mg/ml). For i.p. injection the Tamoxifen stock solution
was diluted 1:10 in sunflower oil (Sigma). As controls, mice were injected with 10% Ethanol in sunflower oil.
DSS and ISCK03 treatment
Mice were administered 3% dextran sulfate sodium salt (colitis-grade; MP Biomedicals) through the drinking water for seven days
during which the animals weremonitored for a specific set of parameters including stool consistency, blood loss, appearance, and%
weight loss. DAI scores upon DSS-induced inflammation were obtained according to (Cooper et al., 1993) with minor modifications.
DAI scores were as follows: stool consistency = normal (0), loose (1), diarrhea (2); blood loss = no loss (0), gross bleeding (1); appear-
ance = normal (0), hunched (1), starey coat (2), lethargic (3); % weight loss = none (0), 0-10 (2), 10-20 (2), > 20 (3). ISCK03 (#15781,Cell Reports 24, 2312–2328.e1–e7, August 28, 2018 e3
Cayman Chemical) was administered via drinking water to the mice at a concentration of 0.1 mg/ml. For lineage tracing experiments,
IF, IHC, or RNA in situ hybridization (ISH) analysis, mice were sacrificed at indicated time points post DSS treatment.
Immunohistochemistry (IHC) analysis
Mouse tissues were fixed overnight in 4% PFA and embedded in paraffin. Human tissues (normal and IBD) were already available as
paraffin blocks from the department of Pathology at the ErasmusMC. Four mm sections were mounted on slides. IHCwas performed
using antibodies against SCF (1:500; Rockland), OLFM4 (1:200; CST), Mki67 (1:200; Novus biologicals) b-catenin (1:500; BD
Biosciences) and CD3 (1:400; Abcam). Briefly, paraffin embedded sections were dewaxed with Xylene and hydrated in 100% and
70% ethanol. Antigen retrieval was performed using pressure cooker pretreatment in a Tris-EDTA buffer (pH 9.0). Slides were
then incubated at 25C in 3% hydrogen peroxidase for 15’ to block endogenous peroxidase activity. Tissue sections were washed
and blocked with 5% BSA in PBS-Tween for 1 hour to then be incubated with the primary antibody overnight at 4C. Slides were
washed twice with PBS-Tween and incubated with Rabbit EnVision+ System-HRP (Dako) or Mouse EnVision+ System-HRP
(Dako) for 30 min. Sections were counterstained with Mayer’s Hematoxylin and dehydration was performed by incubation in 70%
and 100% ethanol followed by Xylene, before slides were mounted using Pertex (Histolab). The quantification of Ki67+ Paneth cells
refers to the amount of crypts containing at least one Ki67+ PC was detected.
The quantification of Olfm4+ cells is based on the average number of Olfm4-positive cells per crypt throughout the length of the
small intestine. The quantification of CD3+ cells is based on the average number of CD3+ -positive cells infiltrating the intestinal
epithelium per villus. For each quantification, at least 50 crypts or villi per mouse, and at least 3 experimental mice were employed.
Immunofluorescence (IF) and lineage tracing analysis
Paraffin embedded tissues were prepared as described for IHC up to the peroxidase blocking step. For cryo-sections, tissue
samples were first dissected and washed with PBS, to then be fixed for 2 hours at 25C with 4% buffered formaldehyde solution
(Klinipath). Tissues were cryo-protected in 30% sucrose (Sigma) overnight at 4C, embedded in OCT (KP cryocompound, Klinipath),
frozen on dry ice, and sectioned at 20C. Tissues were cut in 4-8 mm thick sections. When applicable, sections were incubated in
blocking buffer (5% milk powder in PBS-T) for 30 min. at 25C, and stained with primary antibodies directed against the following
proteins: Mki67 (1:100; Novus biologicals), lysozyme (C19) (1:100; Santa Cruz), lysozyme EC 3.2.1.17 (1:1000; Dako), c-Kit
(D13A2)(1:100; CST), OLFM4 (1:100; CST), Muc2 (H-300) (1:500; Santa Cruz), chromogranin A (1:200; Novus Biologicals), and
DCAMKL1 (1:200; Abcam) in blocking buffer overnight at 4C. After washing in PBS-T, slides were incubated for 2 hours with the
following secondary antibodies: Goat anti-Rabbit IgG (H+L) secondary Antibody, Alexa Fluor 568 conjugate, (1:250; Life Technol-
ogies), Donkey anti-Rabbit IgG (H+L) secondary Antibody, Alexa Fluor 568 conjugate (1:250; Life technologies) or Donkey anti-Goat
secondary Antibody, Alexa Fluor 633 conjugate (1:250; Life technologies). Tissueswere counterstainedwith Alexa Fluor 568Phal-
loidin (1:100; Invitrogen) or Alexa Fluor 633 Phalloidin (1:100; Invitrogen), and DAPI (Sigma) for 30 min. at 25C and washed in
PBS-T. Tissues were mounted in VECTASHIELD HardSet Antifade Mounting Medium (Vector Labs) and imaged with a Zeiss
LSM700 confocal microscope. Images were processed with ImageJ (U.S. National Institutes of Health, Bethesda, MD, USA).
Lineage tracing frequency of LysCreERT2/R26LSL-YFP was quantified by dividing the number of intestinal crypt/villus axes containing
YFP+ ribbons by YFP+ crypts.
RNA in situ hybridization (ISH)
Paraffin embedded tissues were prepared as described for IHC. SCF ISH analysis was performed by using the RNAscope kit
(ACDbio) according to the manufacturer’s instructions. Four mm formalin-fixed, paraffin-embedded tissue sections were pretreated
with heat and protease before hybridization with a target probe to SCF mRNA (RNAscope 2.5 VS Probe- Mm-Kitl (ACDbio)).
An HRP-based signal amplification system was then applied followed by colorimetric development with DAB. Positive staining
was identified as brown, punctate dots. Specificity of the SCF-RNA probes were tested by using PPIB (Cyclophilin B) and DapB
gene (ACDbio) as positive and negative controls, respectively.
Organoid assays
To establish organoid cultures ex vivo, two distinct sources of cells were employed namely either whole crypts or single cell suspen-
sions both from freshly resected mouse intestinal tissues. Whole crypts were extracted from the small intestine by incubating the
minced tissues with 2 mM EDTA for 30 min. at 4C. Crypts were then pelleted and passed through a 70 mm strainer. Whole crypt
cultures were performed as previously described in standard ENR medium (Sato et al., 2009) supplemented, when indicated, with
SCF (150ng/ml; Peprotech), soluble c-kit receptor (500ng/ml; R&D Systems), masitinib (200nM; Selleckchem), rapamycin (10 nM;
Cayman Chemicals), U0126 (1 mM; Cayman Chemicals), LY294002 (5 mM; Cayman Chemicals),and ruxolitinib (0.5 mM; Cayman
Chemicals).
As for organoid reconstitution assays (ORA), isolated crypts were first digested to single cells after incubation with TrypLE (Life
Technologies) and 2000 U/ml-1 Dnase (Sigma) for 10 min. at 37C. Dissociated cells were passed through a 40 mm strainer, stained
with an APC-conjugated CD24 antibody (clone M1/69 BioLegend), and, to exclude non-epithelial cells, with the following Ab’s
for 30min. at 4C: BV421-conjugated TER119 (Biolegend), CD31 (Biolegend), CD45 (Biolegend). For PC analysis, an additional stain-
ing with a PE-conjugated CD117 antibody (Biolegend) was also performed. Cells were then sorted by FACS (BD FACSAriaIII;e4 Cell Reports 24, 2312–2328.e1–e7, August 28, 2018
BDBioscience). Single viable epithelial cells were gated by CD24 and side scatter (SSC), and by negative selection against the above
BV421-conjugated Ab’s and with DAPI to discriminate live from dead cells. Detailed FACS gating strategy for the small intestine
was performed as previously described (Roth et al., 2012). Reconstitution of Lgr5-EGFPhi stem cells (purity > 99%) with PCs
(CD24hiSSChi; purity > 98%) was performed by pelleting sorted cells at 300 g. for 5 minutes in Eppendorf LoBind Tubes, and by
co-incubating them for 15 min. at 25C as previously described (Sato et al., 2011). In order to implement the reconstitution assay
upon activation of sorted cells with SCF, Paneth or Lgr5-EGFPhi cells were first incubated with 150 ng/ml of recombinant murine
SCF for 30 min. at 37C in DMEM F12 before reconstitution. In order to inactivate GSK3b, sorted Paneth and Lgr5+ cells were incu-
bated with standard reconstitution medium + 5 mM Chiron (CHIR99021, Tocris) for 4 days followed by incubation in standard ENR
medium. In order to inhibit PI3K and AKT, sorted PCs were incubated with specific chemical inhibitors NVP-BKM120 for PI3K
(1 mM; Cayman Chemical) and AKT inhibitor VIII for AKT (4mM; Cayman Chemicals) for 30 min., centrifuged at 300 g for 5 min.,
and then washed in 200 mL of Advanced DMEM F12. Following these treatments, Paneth and Lgr5+ stem cells were centrifuged
at 300 g for 5 minutes and subsequently reconstituted by resuspension in 30 mLMatrigel (Corning), and culture in 96Well Flat Bottom
dishes (Corning). Alternatively, they were plated singularly where indicated. The composition of the culturemediumwas as previously
described for whole crypts after supplementation with 10 mMY-27632 (Sigma) and 1mM Jagged-1 (AnaSpec). Brightfield pictures of
organoids were taken using the Zeiss Primovert inverted microscope.
Ex vivo lineage tracing
LysCreERT2/R26LSL-YFP were treated with Tamoxifen as described above to induce Cre recombination. Mice were then either left un-
treated or treated with 3% DSS in drinking water for 7days. 3 days after removal of DSS, intestinal crypts were isolated, single cell
digested and YFP+ cells within the PC gates (CD24hiSSChi) were sorted by FACS. YFP+ PCs (n = 4000) were then plated in 30 ml Ma-
trigel in a single well of a glass bottom 96well plate andmaintained at 37Cand 5%CO2. Culturemedium (as described for the recon-
stitution assay) was changed every other day. For SCF treatments, YFP+ cells from control mice were either left untreated or treated
with 150 ng/ml SCF for 30 min. before plating. Also in this case, culture medium (including 150 ng/ml SCF, for the SCF treated con-
ditions) was replenished on a daily basis. At day 7, organoids were counterstained with 2mg/ml (Hoechst 34580) and imaged using a
Zeiss CLSM510 Meta confocal microscope.
IF analysis of whole-mount intestinal crypts
Whole crypts were extracted from the small intestine by incubating the minced tissues with 2 mM EDTA for 30 min. at 4C. Crypts
were then pelleted and passed through a 70 mm strainer. Pelleted crypts were resuspended either in Advanced DMEM F12 or
Advanced DMEM containing 50 ng/ml recombinant murine SCF ((#250-03, Peprotech), transferred to Eppendorf LoBind microcen-
trifuge tubes (Sigma) and incubated for 10 min. at 37C. Subsequently, crypts were pelleted (300 g, 5 min. at 4C) and fixed with 4%
buffered formaldehyde solution (Klinipath) for 20 min. at 25C. Crypts were washed twice with cold PBS and resuspended in block
(5%milk powder in PBS-T) and incubated for 30 min. at 25C. Afterward, the crypts were stained with primary antibodies against the
following proteins: phospho-GSK3b (Ser9) (1:100; CST), Gsk3b (D5C5Z) (1:100; CST), phospho-Akt (Ser473)(1:100; CST), panAkt
(40d4) (1:100; CST), lysozyme (C19) (1:100; Santa Cruz), in blocking buffer overnight at 4C. After washing in PBS-T, slides were incu-
bated for 2 hours with the following secondary antibodies: goat anti-rabbit IgG (H+L) secondary antibody, Alexa Fluor 568 conju-
gate (1:250, Life Technologies), donkey anti-rabbit IgG (H+L) secondary antibody, Alexa Fluor 568 conjugate (1:250, Life technol-
ogies) or donkey anti-goat secondary antibody, Alexa Fluor 633 conjugate (1:250; Life technologies). Tissues were counterstained
with Alexa Fluor 568 Phalloidin (1:100; Invitrogen) or Alexa Fluor 633 Phalloidin (1:100; Invitrogen) and DAPI (Sigma) for 30 min. at
25C and washed in PBS-T. Crypts were then resuspended in VECTASHIELD HardSet Antifade Mounting Medium (Vector Labs),
transferred to glass slides and covered with a coverslip. Images were taken with a Zeiss LSM700 confocal microscope and
processed with ImageJ (U.S. National Institutes of Health, Bethesda, MD, USA). The relative phospho-GSK3b intensity of PCs
was quantified by setting PCs as region of interest (ROI) and measuring the average intensity of the phospho-GSK3b signal within
the ROI. PCs of at least 10 crypts per mouse per condition were analyzed.
Western blot analysis
Paneth and Lgr5-EGFP cells from C57BL/6J mice were extracted and FACS sorted as described for the organoid reconstitution
assay. Sorted cells were incubated either in Advanced DMEM F12 medium or medium containing 50 ng/ml recombinant murine
SCF (Peprotech) for 30 min. at 25C. Subsequently, cells were lysed in RIPA lysis buffer (50 mM TrisHCl pH 7.5, 150 mM NaCl,
0.5%TritonX, 10%Glycerol, 10%DTT, and 1x NuPAGE LDS Sample Buffer (Life Technologies)). Lysates were subjected to standard
SDS-PAGE and western blotting procedures using primary antibodies directed against c-Kit (D13A2)(1:1000; CST), phospho-Akt
(Ser473) (1:1000; CST), panAkt (40d4) (1:2000; CST), phospho-GSK3b (Ser9) (1:1000; CST), Gsk3b (D5C5Z) (1:1000; CST), GFP
(1:500; Genetex) and b-actin (D6A8) (1:1000; CST) and anti-Rabbit-HRP (1:1000), anti-Mouse-HRP (1:1000) secondary antibodies
(Life Technologies) as well as HRP-Streptavidin Conjugate (1:1000; Invitrogen). Signal detection was performed by using the
enhanced chemiluminescence system (ECL; Thermo Fisher Scientific, Schwerte, Germany) and the Molecular Imager Gel Doc
XR System (Bio-Rad). Protein bands were quantified using ImageJ (U.S. National Institutes of Health, Bethesda, MD, USA). pAkt
and phospho-Gsk3b bandswere normalized to the total Akt or Gsk3b bands, respectively, as well as to b-actin bands and fold values
were calculated upon comparison with the negative background of the C57BL/6J lysates. As no significant differences between theCell Reports 24, 2312–2328.e1–e7, August 28, 2018 e5
fold inductions of both ways of normalization was detected we used the normalization of phospho versus total protein bands as result
in our manuscript.
FACS quantification and analysis of Lgr5+-, Paneth-, and YFP+ cells by
Intestinal crypts from untreated or DS- treated Lgr5EGFP-IRES-creERT2 or tamoxifen-injected LysCreERT2/R26LSL-YFP mice were isolated,
single cell digested, and subjected to FACS analysis. Lgr5+ and Paneth (CD24hiSSChi) cells were identified and quantified by using
previously established gates (Roth et al., 2012). For control or DSS treated LysCreERT2/R26LSL-YFP mice, YFP+ and YFP- cells were
identified as in Figure 4B, and the percentage of YFP+ and YFP- cells within and outside the PC gate (CD24hiSSChi) was quantified.
TOP/FOP reporter assay
For the b-catenin/TCF reporter assay (TOP-Flash assay), cells were plated on 24-well plates and, when 70% confluence was
reached, transfected by Fugene HD (Promega) with 250 ng of the TOP-Flash or FOPFlash reporter constructs together with 25 ng
of the Renilla luciferase vector for normalization purposes. SCF was added were indicated at 150ng/ml. Luciferase activity was
measured by Dual–Luciferase Reporter Assay System (Promega) 48h post-transfection. Luminescence was measured using a
Glomax Luminometer.
RNA isolation, RNA sequencing and quantitative real-time PCR
PCs [CD24hiSSChi] and Lgr5+ stem/progenitor cells derived from Lgr5-EGFPmice were sorted as described for the organoid recon-
stitution assay from crypt preparations of the small intestine and RNA was isolated from cells using TRIzolTM Reagent (ThermoFisher
Scientific) according to the manufacturer’s instructions. RNA quality and quantity was evaluated on a 2100 Bio-analyzer (Agilent) us-
ing the Agilent RNA 6000 Pico Kit (Agilent Technologies). For RNA sequencing analysis, RNA samples were further processed by
GATC-Biotech (Konstanz, Germany) according to the INVIEWTM Transcriptome Explore library preparation protocol (Illumina based).
RNA-seq data of PC samples (n = 7) was performed using UCSC mouse genome build mm10 (reference strain C57BL/6J) and
GENCODE annotation release M15 (GRCm38.p5). FASTQC (v0.11.5) (Schmieder and Edwards, 2011) was applied on the single-
end FASTQ files for quality control, both before and after running trimmomatic (v0.36) (Bolger et al., 2014), which removed TrueSeq
adaptor sequences. STAR (v2.5.3a) (Dobin et al., 2013) was used as aligner, with 2-pass mapping for each sample separately.
Mapping quality plot was generated and checked based on sambamba Flagstat statistics (Tarasov et al., 2015). Count files, with
the number of reads for each gene were created with subread FeatureCounts (1.5.2) (Liao et al., 2014). R (version 3.4.3) was used
for further calculating statistics and data visualizations. Differential expression analysis were performed with condition ‘DSS treat-
ment’ (n = 4) versus ‘Control’ (n = 3) using the DESeq2 package (v1.18.1) (Love et al., 2014) and theWald-test. P values were adjusted
using the Benjamini-Hochberg procedure. Heatmap visualization (Z-Scores averages per condition) was performed with the ggplot2
package (v2.1.0) on Regularized Log (from the DESeq2 package) transformed data and Z-Score were calculated with the base R
‘scale’ function (column scaling, followed by column centering). For quantitative RT-PCR purposes, RNA was converted into
cDNA using the High Capacity RNA-to-cDNA kit (Applied Biosystems) and employed in a pre-amplification step using the
TaqmanPreAmp Master Mix (Applied Biosystems) according to manufacturer’s instructions. The linearity of the pre-amplification
reaction was controlled for all primers. Assays were carried out as duplicate reactions using the 7500 Real Time system (Applied Bio-
systems). Finally, quantitative PCR was performed using inventoried TaqMan assays (Applied Biosystems) according to manufac-
turer’s instructions. The Actb gene was employed as housekeeping gene. The assay number of the Taqman probes employed in
this study for qRT-PCR purposes: Axin2Mm00443610_m1, ActbMm02619580_g1, JunMm00495062_s1, Ccnd1Mm00432359_m1
QUANTIFICATION AND STATISTICAL ANALYSES
Statistical an graphical analyses was conducted using FIJI and Microsoft Excel 2016. The immunofluorescent and immunohisto-
chemistry as well as in situ hybridization on mouse tissues were performed on at least 3 sections of at least 3 mice per experimental
condition. Immunohistochemistry and Immunofluorescence on human tissues were performed on at least 3 sections from 2 healthy,
4 CD and 5 UC patients. Weight loss graphs and DAI scores where related to the following number of mice: treated with 3% DSS
alone n = 6, ISCK03 alone n = 3, and 3% DSS + ISCK03 n = 6. All whole crypt organoid assays and ORA assays where plated in
triplicates per condition and repeated at least 3 independent times. All FACS experiments were obtained from at least 3 mice
per experimental condition.
For Figures 2A, 2B, S2A, S4A, and S4B, the FACS analyses were performed from cells of 5 independent mice per condition. In
Figure 2B and Figure S4B, the average% of cells within the specified gates was quantified. In Figures 2D and 7D, the lineage tracing
frequency of Lgr5EGFP-IRES-creERT2/R26LSL-RFP and LysCreERT2/R26LSL-YFP was quantified by dividing the number of intestinal crypt/vil-
lus axes containing YFP+ ribbons by YFP+ crypts. At least 200 crypts per mouse of at least 3 experimental mice per condition were
quantified. For Figure 2F, the average number of OLFM4+ cells per crypt of at least 50 crypts per mouse (n = 3 per condition) was
quantified. For Figures 3B and 7C, the average percentage of crypts with at least one Ki67+ PC was quantified. At least 50 crypts per
mouse of at least 3 independent mice per condition were analyzed. In Figures 5C and 6C, pAkt and phospho-Gsk3b bands were
normalized to the total Akt or Gsk3b bands, respectively, as well as to b-actin bands and fold values were calculated upon compar-
ison with the negative background of the C57BL/6J lysates. As no significant differences between the fold inductions of both ways ofe6 Cell Reports 24, 2312–2328.e1–e7, August 28, 2018
normalization was detected, we used the normalization of phospho versus total protein bands as result in our manuscript. For Fig-
ure 6B, PCs were set as ROI (region of interest and the average intensity of the phospho-GSK3b signal within the ROI wasmeasured.
Results represent the average intensity of PCs of at least 30 crypts per mouse (n = 3/condition). Analysis was performed using the Fiji
software. For Figure S1F, the quantification of CD3+ cells is based on the average number of CD3+ -positive cells infiltrating the
intestinal epithelium per villus. For each quantification, at least 50 crypts or villi per mouse, and at least 3 experimental mice per
condition were analyzed. Statistical comparisons between two groups were performed using unpaired two-tailed Student’s t test
and p values are indicated in the corresponding graphs. p values < 0.05 were considered as statistically significant. Error bars are
indicated as MEAN (SD).
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA-seq data reported in this paper is GEO: GSE117216 (Edgar et al., 2002).Cell Reports 24, 2312–2328.e1–e7, August 28, 2018 e7
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Supplementary Fig.1 (related to Fig. 1) 
A B 
Mouse ID Genotype Treatment Stool consistency (0-2) Blood loss (0-1) Appearance (0-3) Weight loss (0-3) DAI score 
1 C57BL/6J DSS Diarrhea (2) Gross bleeding (1) Starey coat (2) 10,18% (2) 7 
2 C57BL/6J DSS Loose (1) No blood (0) hunched (1) 10,75% (2) 4 
3 C57BL/6J DSS Loose (1) Gross bleeding (1) hunched (1) 7,5% (1) 4 
4 C57BL/6J DSS Loose (1) No blood (0) hunched (1) 9% (1) 3 
5 C57BL/6J DSS Loose (1) No blood (0) Starey coat (2) 7,27% (1) 4 
6 C57BL/6J DSS Diarrhea (2) Gross bleeding (1) Hunched (1) 10% (2) 6 
7 C57BL/6J DSS+ISCK03 Diarrhea (2) Gross bleeding (1) Lethargic (3) 20,3% (3) 9 
8 C57BL/6J DSS+ISCK03 Diarrhea (2) Gross bleeding (1) Starey coat (2) 22,5% (3) 8 
9 C57BL/6J DSS+ISCK03 Diarrhea (2) Gross bleeding (1) Lethargic (3) 16,73% (2) 8 
10 C57BL/6J DSS+ISCK03 Diarrhea (2) Gross bleeding (1) Starey coat (2) 16,96% (2) 7 
11 C57BL/6J DSS+ISCK03 Diarrhea (2) Gross bleeding (1) Lethargic (3) 19,91% (2) 8 
12 C57BL/6J DSS+ISCK03 Diarrhea (2) Gross bleeding (1) Lethargic (3) 19,52% (2) 8 
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Supplementary Figure 1 (related to Figure 1) 
A) Comparison of SCF expression of healthy colonic (left) and colonic tissues of patients with ulcerative colitis. 
Picture shows a representative example of 2 healthy and 5 UC patients (scale bars = 100 µm). 
B) Lysozyme immunostaining of colonic tissues of patients with ulcerative colitis. Picture shows a representative 
example of metaplastic Paneth cells in the colon found in 3 out of 5 patients (scale bar = 100µm). 
C) SCF RNA in situ hybridisation on small intestinal tissues of control (left) and DSS treated mice (right) 1 day 
after removal of DSS showing increased SCF RNA levels in the intestinal epithelium and submucosa of inflamed 
mice. PPIB RNA probes were used as positive controls. Pictures show representative examples of n= 3 mice; scale 
bar = 200µm). 
D) Table of DAI scoring parameters of mice treated for 7 days with DSS or DSS + ISCK. Mice were sacrificed one 
day after stop of treatment. Mice treated with ISCK03 alone (n=3) did show normal stool consistency, no blood loss, 
normal appearance and no weight loss and were not included in the table.  
E) CD3 immunhistochemistry analysis of intestinal tissues from control and DSS, ISCK03 or DSS + ISCK03 treated 
mice 1 day after stop of treatment (asterisks indicate infiltrating CD3
+
 T-lymphocytes; scale bar = 50 µm). 
F) Quantification of infiltrating CD3
+
 T-lymphocytes/villus in control, DSS and DSS + ISCK03 treated mice 
described in A (*p< 0.05; n.s. = not significant; n=3).  
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Supplementary Figure 2 (related to Figure 2) 
A) FACS analysis of Lgr5
+
 and Paneth cells (C24
high
/SSC
high
) in control or DSS treated mice 3 days after withdrawal 
of DSS (FACS plots are representrative of 5 independent experiments;  cells within the Paneth cell gate are labelled 
in red; Lgr5-EGFP+ cells, as defined in Fig. 2A, are labelled in green). 
B) Confocal microscopy images of small intestinal tissues of Tamoxifen treated Lgr5
-EGFP-IRES-CreERT2
/R26
-LSL-RFP
 
mice subjected to normal drinking water or 3% DSS. Tissues were harvested 3 days after withdrawal of DSS. 
Picture shows an overview of Lgr5 lineage tracings in small intestinal tissues (scale bar = 200 µm).  
C) Olfm4 immunohistochemistry analysis of intestinal tissues from control and DSS treated mice 1 day after 
removal of DSS. Picture shows an overview of Olfm4 staining in small intestinal tissues (scale bar = 250 µm).  
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Supplementary Fig. 3 (related to Fig. 3) 
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Supplementary Figure 3 (related to Figure 3) 
A) Ki67/lysozyme double immunostaining of small intestinal tissues of untreated (upper panel) or DSS treated mice 
(lower panel). Tissues were harvested 1 day after DSS treatment (arrow indicates a Ki67/lysozyme double positive 
cell; scale bar = 25 µm) 
B) Ki67/lysozyme double immunostaining of small intestinal tissues of a CD patient (arrow indicates a 
Ki67/lysozyme double positive cell; scale bar = 25 µm) 
  
Supplementary Fig. 4 (related to Fig. 4) 
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Supplementary Figure 4 (related to Figure 4) 
A) FACS analysis of Paneth cells and YFP
+
 cells of Tamoxifen injected Lyz-Cre/R26-LSL-YFP mice. Upper left 
plot: selection of Paneth cells using a standard CD24
high
/SSC
high
 gate on total live/Lin- cells. Red labelled cells 
within the highlighted CD24
high
/SSC
high
 gate are YFP
-
 Paneth cells, green cells are YFP
+
 cells. Upper right plot: 
CD24
high
/SSC
high
 cells are subdivided in YFP
+ 
and YFP
-
. Lower left plot: Total live/Lin- cells were subdivided in 
YFP
+ 
and YFP
-
. Lower right plot: YFP+ cells were analyzed for their distribution in the (CD24
high
/SSC
high
) Paneth 
cell region. 
B) Quantification of FACS analysis described in B. Approximately 12% of Paneth cells show expression of YFP. 
97% of YFP
+
 cells were detected within the Paneth cell gate (n=5). 
C) Confocal microscopy analysis of Tamoxifen injected Lyz-Cre/R26-LSL-YFP mice using antibodies against 
lysozyme and c-Kit. YFP labelled cells express lysozyme and c-Kit (scale bar = 25 µm). 
D) Analysis of YFP expression in Lyz-Cre/R26-LSL-YFP mice injected with 10% ethanol in sunflower oil (control, 
upper panel) or Tamoxifen (lower panel) (scale bar = 200µm). 
E) Confocal microscopy analysis of Tamoxifen injected Lyz-Cre/R26-LSL-YFP mice using antibodies against 
lysozyme. The mice were treated for 7 days with 3% DSS and analyzed at day 1 after withdrawal of DSS. Paneth 
cells are only detected at the base of the crypt and YFP expression could be detected only in lysozyme
+
 Paneth cells 
(scale bar = 100µm). 
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Supplementary Fig. 5 (related to Fig. 5) 
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Supplementary Figure 5 (related to Figure 5) 
A) Number of organoids derived from untreated or SCF treated (150 ng/ml) whole intestinal crypts. Crypts were 
plated in the presence or absence of inhibitors against Mapk  (U-0126, 1 µM), mTor (Rapamycin 10 nM), PI3K 
(LY294002, 0.5 µM) or Jak1 (Ruxolitinib, 0.5µM) (**p< 0.01, n=3). 
B) Immunostainings for total-Akt in intestinal crypts of Lgr5-EGFP mice (scale bar = 25µm). Picture shows one 
representative example of at least 3 independent experiments. 
C) Immunostainings for phospho-Akt and lysozyme in untreated or SCF treated intestinal crypts of Lgr5-EGFP mice 
(arrows indicate phospho-Akt/lysozyme double positive cells, scale bar = 25µm). Picture shows one representative 
example of at least 3 independent experiments. 
D) RNA sequencing analysis of Paneth cells of control or DSS treated mice 3 days after withdrawal of DSS. 
Heatmap shows differentially expression of  stem cell related genes.  
  
Supplementary Fig. 6 (related to Fig. 6) 
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Supplementary Figure 6 (related to Figure 6) 
A) Immunostainings for total-GSK3β in intestinal crypts of Lgr5-EGFP mice (scale bar = 25µm). Picture shows one 
representative example of at least 3 independent experiments. 
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Supplementary Fig. 7 (related to Fig. 7) 
A 
D
A
P
I 
Ly
so
zy
m
e 
K
i6
7 
O
ve
rla
y 
Supplementary Figure 7 (related to Figure 7) 
A) Ki67/lysozyme double immunostaining of small intestinal tissues of untreated (left panel), DSS treated (middle 
left panel), DSS + ISCK03 treated (middle right panel) or ISCK03 treated mice (right panel) or ISCK03 treated mice 
(right panel). Tissues were harvested 1 day after DSS treatment (arrows indicates a Ki67/lysozyme double positive 
cell; scale bar = 25 µm). 
